SVA News

CORRECTION - Signature Aviation Introduces Signature Access, Making Private Aviation Pricing Simpler, More Predictable and Transparent

Signature Aviation and UrbanV Launch Signature UrbanV Alliance to Develop and Operate AAM Infrastructure Across the United States

Seraxis and Sernova Announce Appointment of Former FDA Medical Officer Dr. Patricia Beaston as Chief Medical Officer of Seraxis and Post Merger BetaNova Biotherapeutics

Signature Aviation Expands Operations at Van Nuys Airport with Acquisition of Castle & Cooke Aviation Services LLC

Sernova Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investor Conference

Sernova and Seraxis Enter Definitive Merger Agreement to Create a Differentiated Type 1 Diabetes Islet Cell-Replacement Biotech Company, BetaNova Biotherapeutics

SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend

Signature Aviation Earns Great Place To Work® Certification for the Third Consecutive Year

SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements

SINOVAC Reports Unaudited and Unreviewed Second Half of 2025 Financial Results and Files 2025 Annual Report on Form 20-F